Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,424,317
+$511,039 QoQ
Shares Held
13,608
+1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,559
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILTON CAPITAL MANAGEMENT LLC holds $189,707,778 across 12 Drug Manufacturers - General names. ABBV ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
69,286 | $83,103,713 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
411,727 | $52,017,589 | |
| 3 | AZN |
Astrazeneca PLC
|
201,189 | $38,149,458 | |
| 4 | JNJ |
Johnson & Johnson
|
21,048 | $5,345,560 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,329 | $3,768,776 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
13,608 | $3,424,317 | |
| 7 | AMGN |
Amgen Inc
|
4,095 | $1,482,881 | |
| 8 | NVS |
Novartis AG
|
7,290 | $1,142,488 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,424,317 | 13,608 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,913,278 | 13,395 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,072,048 | 13,445 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,122,085 | 13,484 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,450,555 | 13,202 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,757,911 | 13,163 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,382,423 | 13,407 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,662,227 | 13,481 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,350,510 | 13,704 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,451,794 | 13,464 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,274,339 | 14,676 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,176,723 | 14,603 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,032,132 | 15,083 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,338,436 | 14,673 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,372,919 | 14,683 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,003,352 | 14,927 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,312,409 | 15,098 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $2,719,719 | 16,777 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,272,012 | 16,780 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,810,597 | 16,785 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,896,294 | 16,835 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,777,188 | 16,422 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,760,474 | 16,430 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,444,096 | 16,487 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $440,533 | 4,487 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $353,216 | 4,636 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||